(RTTNews) - Cognition Therapeutics Inc. (CGTX), a clinical-stage biopharmaceutical company, on Monday, provided an update on a biomarker analysis from its phase II SHINE study of CT1812in ...
A simple 3-biomarker score meaningfully improves risk stratification for both prevalent and incident rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), supporting a targeted, ...
In 2020, as many as 5.8 million Americans were living with Alzheimer’s Disease (AD)—a number projected to nearly triple to 14 million people by 2060. 1 As changes in the brain can begin years before ...
Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...
In a recent editorial published in Current Pharmaceutical Analysis (Volume 18, Issue 6, 2022), researchers Dr. Behrouz Seyfinejad and Dr. Abolghasem Jouyban highlight the importance of method ...
Non-invasive EEG biomarker identifies risk of future cognitive decline long before diagnosis, reinforcing BrainScope's strategic focus on early, actionable dementia detection. ROCKVILLE, ...
To improve ovarian cancer screening, researchers led by Johns Hopkins University’s Victor E. Velculescu, MD, PhD, developed a combination liquid biopsy approach. It has three components: measurements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results